Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 7, 2022
An Experimental Generator for Production of High-Purity 212Pb for Use in RadiopharmaceuticalsRuth Gong Li, Vilde Yuli Stenberg, Roy Hartvig Larsen
Cancers|March 6, 2021
Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate CancerAsta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland, et al.
Medical Oncology (Northwood, London, England)|July 22, 2025
Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer modelsRugile Liukaityte, Vilde Yuli Stenberg, Andrius Kleinauskas, et al.
Frontiers in Medicine|February 3, 2023
Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approachAsta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|January 11, 2020
Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancerVilde Yuli Stenberg, Asta Juzeniene, Qingqi Chen, et al.
Scientific Reports|November 29, 2025
Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001Vilde Yuli Stenberg, Rugile Liukaityte, Sandra Kvarsvik Kristiansen, et al.
Frontiers in Medicine|December 12, 2022
Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcomaAnna Julie Kjøl Tornes, Vilde Yuli Stenberg, Roy Hartvig Larsen, et al.
International Journal of Molecular Sciences|June 2, 2021
Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate CancerVilde Yuli Stenberg, Roy Hartvig Larsen, Li-Wei Ma, et al.
Cancers|June 10, 2022
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001Vilde Yuli Stenberg, Anna Julie Kjøl Tornes, Hogne Røed Nilsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer XenograftsAnna Julie Kjøl Høyvik, Vilde Yuli Stenberg, Rugile Liukaityte, et al.
Pageof 1